These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34880154)

  • 1. Ischemic and Bleeding Events in PENDULUM Patients With High Bleeding Risk and High Platelet Reactivity.
    Iijima R; Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Akasaka T; Shinke T; Ueno T; Hirayama A; Uemura S; Harada A; Kuroda T; Takita A; Murakami Y; Saito S; Nakamura M
    Circ J; 2022 Apr; 86(5):763-771. PubMed ID: 34880154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.
    Nakamura M; Kadota K; Takahashi A; Kanda J; Anzai H; Ishii Y; Shibata Y; Yasaka Y; Takamisawa I; Yamaguchi J; Takeda Y; Harada A; Motohashi T; Iijima R; Uemura S; Murakami Y;
    J Am Heart Assoc; 2020 May; 9(10):e015439. PubMed ID: 32394794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes After Percutaneous Coronary Intervention in East Asian Patients　- 30-Month Results of the PENDULUM Registry.
    Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Akasaka T; Shinke T; Ueno T; Hirayama A; Uemura S; Harada A; Kuroda T; Takita A; Iijima R; Murakami Y; Saito S; Nakamura M
    Circ J; 2022 Aug; 86(9):1339-1349. PubMed ID: 35569930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI.
    Wang HY; Dou KF; Yin D; Zhang D; Gao RL; Yang YJ
    BMC Cardiovasc Disord; 2020 Jul; 20(1):313. PubMed ID: 32611318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
    Sorrentino S; Claessen BE; Chandiramani R; Guedeney P; Vogel B; Baber U; Rau V; Wang J; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Liu Y; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
    Circulation; 2020 Mar; 141(11):891-901. PubMed ID: 31992063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic/bleeding event after short dual-antiplatelet therapy in patients with high bleeding risk: Sub-analysis of the MODEL U-SES study.
    Hioki H; Kozuma K; Kinoshita Y; Nanasato M; Ito Y; Yamaguchi J; Shiode N; Hibi K; Tanabe K; Ako J; Morino Y; Hirohata A; Sonoda S; Nakagawa Y; Okada H; Nakagami T; Takamisawa I; Ando K; Abe M; Ikari Y
    J Cardiol; 2021 Aug; 78(2):107-113. PubMed ID: 33875313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study.
    Wang HY; Wang Y; Yin D; Gao RL; Yang YJ; Xu B; Dou KF
    J Interv Cardiol; 2020; 2020():2985435. PubMed ID: 32405273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent.
    Okabe K; Miura K; Shima Y; Ikuta A; Taguchi Y; Takahashi K; Osakada K; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Circ J; 2022 Aug; 86(9):1379-1387. PubMed ID: 35400715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ischemic risk factors on long-term outcomes in patients with and without high bleeding risk.
    Shima Y; Miura K; Shimada T; Ohya M; Murai R; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Int J Cardiol; 2021 Mar; 326():12-18. PubMed ID: 33152414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
    Roongsangmanoon W; Wongsoasup A; Chichareon P; Suwannasom P; Chandavimol M; Limpijankit T; Srimahachota S; Hutayanon P; Kiatchoosakun S; Siriwiwattnakul N; Promlikitchai P; Siriyotha S; Thakkinstian A; Sansanayudh N
    Int J Cardiol; 2023 Oct; 388():131167. PubMed ID: 37429447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).
    Kirtane AJ; Parikh PB; Stuckey TD; Xu K; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Parvataneni R; Maehara A; Généreux P; Mehran R; Stone GW
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1978-1987. PubMed ID: 26738669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
    Mangiacapra F; Patti G; Barbato E; Peace AJ; Ricottini E; Vizzi V; Gatto L; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2012 Mar; 5(3):281-9. PubMed ID: 22440493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry.
    Nakamura M; Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Iijima R; Harada A; Kuroda T; Murakami Y
    EuroIntervention; 2021 Feb; 16(14):1154-1162. PubMed ID: 32624464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
    Escaned J; Cao D; Baber U; Nicolas J; Sartori S; Zhang Z; Dangas G; Angiolillo DJ; Briguori C; Cohen DJ; Collier T; Dudek D; Gibson M; Gil R; Huber K; Kaul U; Kornowski R; Krucoff MW; Kunadian V; Mehta S; Moliterno DJ; Ohman EM; Oldroyd KG; Sardella G; Sharma SK; Shlofmitz R; Weisz G; Witzenbichler B; Pocock S; Mehran R
    Eur Heart J; 2021 Dec; 42(45):4624-4634. PubMed ID: 34662382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between platelet aggregation and stroke risk after percutaneous coronary intervention: a PENDULUM analysis.
    Matsumaru Y; Kitazono T; Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Akasaka T; Shinke T; Ueno T; Hirayama A; Uemura S; Kuroda T; Takita A; Harada A; Iijima R; Murakami Y; Saito S; Nakamura M
    Heart Vessels; 2022 Jun; 37(6):942-953. PubMed ID: 34973085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.
    Valgimigli M; Cao D; Angiolillo DJ; Bangalore S; Bhatt DL; Ge J; Hermiller J; Makkar RR; Neumann FJ; Saito S; Picon H; Toelg R; Maksoud A; Chehab BM; Choi JW; Campo G; De la Torre Hernandez JM; Kunadian V; Sardella G; Thiele H; Varenne O; Vranckx P; Windecker S; Zhou Y; Krucoff MW; Ruster K; Zheng Y; Mehran R;
    J Am Coll Cardiol; 2021 Nov; 78(21):2060-2072. PubMed ID: 34794687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial.
    Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
    Cardiovasc Interv Ther; 2021 Jan; 36(1):91-103. PubMed ID: 32086787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
    Spirito A; Cohen R; Sartori S; Vogel B; Baber U; Pileggi B; Smith K; Nicosia D; Kamaleldin K; Farhan S; Kini A; Sharma SK; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2024 Feb; 103(3):425-434. PubMed ID: 38314901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal variations in ischemic and bleeding event risks after acute coronary syndrome during dual antiplatelet therapy.
    Fujii T; Kasai S; Kawamura Y; Yoshimachi F; Ikari Y
    Int J Cardiol; 2023 Dec; 392():131340. PubMed ID: 37678433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding and ischemic events during dual antiplatelet therapy after second-generation drug-eluting stent implantation in hemodialysis patients.
    Shimizu A; Sonoda S; Muraoka Y; Setoyama K; Inoue K; Miura T; Anai R; Sanuki Y; Miyamoto T; Oginosawa Y; Tsuda Y; Araki M; Otsuji Y
    J Cardiol; 2019 Jun; 73(6):470-478. PubMed ID: 30591321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.